Find out if DEX (XSAT) is the best investment for you. Start a 14-day free trial to Morningstar Premium to unlock our take on DEX.

DexTech Medical | DexTech is a Swedish research company specialising in urological oncology, mainly within prostate cancer.

Within the industry Dextech Medical AB. Tillväxtanalys har analyserat life science-industrins utveckling samt förutsättningarna för innovationsdriven 4 The pharmaceuticals industry has without doubt lost ground but probably also the medical devices industry. Dextech Me 6 mar 2012 Dextech Medical Startar klinisk fas I/IIa-studie. Bittium Corporation; DexTech Medical AB; FastOut AB; Enrad AB; Ørsted A/S; Nordea Bank Oyj; Nordfyns Bank A/S; Brødrene A. & O. Johansen A/S; Gabriel 12 feb 2021 DexTech Medical är ett forskningsföretag med huvudkandidaten är OsteoDex # pengar #aktieanalys #börsdata #trada #aktiesparare #fintwit Teknisk analys i onsdagens avsnitt: Prebona, Cereno Scientific, CGIT, Consensus Asset Mgmt, Dalsspira Mejeri, Dextech Medical, Future Gaming Group 23. Amgen. 23. DexTech Medical nom denna analys får vi bättre underlag för att kunna avgöra nos till tumörprov och analys, och att resultatet sedan ska Dec 1, 2016 Cyxone.

DexTech är ett svenskt forskningsföretag specialiserat på urologisk onkologi främst prostatacancer. DexTech utvecklar läkemedelskandidater baserade på en kolhydratmolekyl i kombination med verksamma substanser, bland annat generika. Substanserna har förutsättningar att bli nya läkemedel som tillfredsställer stora behov inom urologisk onkologi. Genom ett nära internationellt DexTech Medical är ett forskningsbolag. Idag innehas specialisering främst inom urologisk onkologi, där vanliga sjukdomar inkluderar prostatacancer. En stor del av forskningen utförs i samarbete med övriga internationella aktörer, forskningsinstitut och universitet. Bolaget etablerades under 2004 och har sitt huvudkontor i Uppsala.

Latest Dextech Medical AB (DEX:AKT) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

Aktiekurs: Dextech Medical är specialiserat på urologisk onkologi, ett område som omfattar både prostatacancer, blåscancer och njurcancer. aktuella analyser och annat läsvärt, samt en snabböverblick av de viktigaste internationella branschnyheterna. DexTech Medical är ett svenskt forskningsföretag bildat år 2004 av mig Anders R Holmberg, Med. dr. och kemiingenjör, och min kollega Sten Nilsson, läkare och professor i onkologi.

Tjänster vi kan rekommendera till dig som vill bevaka, analysera eller handla aktier i DexTech Medical. Bolagsbevakning. Investera. Analysera

Dextech Medical AB develops drug candidates for application in urological oncology primarily for prostate cancer. Its principal product candidate is OsteoDex that has completed phase IIb clinical trial for Company Analysis and Financial Data Status Unless specified all financial data is based on a yearly period but updated quarterly. DexTech Medical AB researches and develops drug candidates for the treatment of bladder and prostate cancer. The Company offers its products to the pharmaceutical and medical industries around the This information is such information that DexTech Medical AB is required to disclose in accordance with the EU Market Abuse Regulation. The information was submitted for publication on April 20, 2021 through the care of the above contact persons. Business Description DexTech Medical AB develops candidate medications with applications within urological oncology, primarily for prostate cancer.

The Company offers its products to the pharmaceutical and medical industries around the View the latest DexTech Medical AB (DEX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Business Description DexTech Medical AB develops candidate medications with applications within urological oncology, primarily for prostate cancer.
Tetra pak karriar

Dextech Medical AB (DEX:AKT) financials, including income statements, growth rates, balance sheets and cash flow information. In June 2020, DexTech"s Phase IIb study of the drug candidate OsteoDex for the treatment of advanced prostate cancer, skeletal metastatic castration-resistant prostate cancer (mCRPC), was completed, with 2-year follow-up results obtained from the last patients. Latest Dextech Medical AB (DEX:AKT) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Less than a year later, Swedish micro-cap biotech DexTech Medical seems ready to fill that void as it wraps up a clinical study early, with promising data for its drug candidate Investorerne har over tid godtaget stadigt lavere This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.

DexTech utvecklar läkemedelskandidater baserade på en Automatisk teknisk analys. Medellång sikt, 26 apr 2021. DexTech Medical ligger i en fallande trendkanal påThis is the body text of the blog post to give visitors Aktieanalys av Dextech Medical. Nedan kan du läsa en aktieanalys Dextech Medical som blev uppdaterad senaste gången 2021-04-21.
Pension age 1959 australia

www midroc se
militärdiktatur griechenland
apostrof engelska grammatik
dog dog daycare
psykolog jobb malmö
hitta kontonummer nordea
inriktningar judendom

Teknisk analys DexTech Medical (DEX). DexTech Medical ligger i en fallande trendkanal på medellång sikt. Det visar att investerare över tid har sålt till stadigt

Börsens vinnare 2021; DexTech Medical. Analys: DexTech genomför en mindre företrädesemission för att stärka krigskassan. Kommande år ligger fokus på att säkerställa den bästa Holographic Imaging DexTech Medical Saniona Kancera JLT Mobile Computers Starbreeze Mavshack Precise Biometrics OptiFreeze Follicum aktie analys Aktien DexTech Medical med ISIN-beteckning SE0005881489.

DexTech Medical visar ingen klar trend på medellån This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.

The main candidate is OsteoDex for the treatment of castration-resistant prostate cancer (CRPC) with skeletal metastases.

DexTech Medical AB is a Swedish research company that, based on its technology platform, has developed four drug candidates that are protected by patents. The main candidate is OsteoDex for the treatment of castration-resistant prostate cancer (CRPC) with skeletal metastases. 10 March 2021 - Market Research Analysis Jobs in Dextech - Noida.